Acetylation is an important, reversible post-translational modification
affecting histone and non-histone proteins with critical roles in gene
transcription, DNA replication, DNA repair, and cell cycle progression. Key
regulatory enzymes include histone deacetylase (HDACs) and histone
acetyltransferases (HATs). Overexpressed HDACs have been identified in many
human cancers, resulting in repressed chromatin states that interfere with vital
tumor suppressor functions. Inhibition of HDAC activity has been pursued as a
mechanism for re-activating repressed genes in cancers, with some HDAC
inhibitors showing promise in the clinical setting. Dietary compounds and their
metabolites also have been shown to modulate HDAC activity or expression. Out of
this body of research, attention increasingly has shifted towards non-histone
targets of HDACs and HATs, such as transcriptions factors, hormone receptors,
DNA repair proteins, and cytoskeletal components. These aspects are covered in
present review, along with the possible clinic significance. Where such data are
available, examples are cited from the literature of studies with short chain
fatty acids, polyphenols, isoflavones, indoles, organosulfur compounds,
organoselenium compounds, sesquiterpene lactones, isoflavones, and various
miscellaneous agents. By virtue of their effects on both histone and non-histone
proteins, dietary chemopreventive agents modulate the cellular acetylome in ways
that are only now becoming apparent. A better understanding of the molecular
mechanisms will likely enhance the potential to more effectively combat diseases
harboring altered epigenetic landscapes and dysregulated protein signaling.
Dietary chemopreventive agents modulate the cellular acetylome by
affecting both histone and non-histone proteins, which will likely enhance their
potential to more effectively combat diseases harboring altered epigenetic
landscapes.